We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Mandatory Electronic Adverse Event Reporting Rule
FDA Finalizes Mandatory Electronic Adverse Event Reporting Rule
Drug and biologic manufacturers have one year to update their systems and begin submitting adverse event reports electronically to the FDA instead of via paper.